5JM4 image
Deposition Date 2016-04-28
Release Date 2017-05-10
Last Version Date 2024-01-10
Entry Detail
PDB ID:
5JM4
Title:
Crystal structure of 14-3-3zeta in complex with a cyclic peptide involving an adamantyl and a dicarboxy side chain
Biological Source:
Source Organism:
Host Organism:
Method Details:
Experimental Method:
Resolution:
2.34 Å
R-Value Free:
0.24
R-Value Work:
0.19
R-Value Observed:
0.20
Space Group:
P 21 21 21
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:14-3-3 protein zeta/delta
Gene (Uniprot):YWHAZ
Chain IDs:A, B
Chain Length:230
Number of Molecules:2
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Molecule:GLN-GLY-MKD-ANG-ASP-MKD-LEU-ASP-LEU-ALA-CLU
Chain IDs:C (auth: D), D (auth: E)
Chain Length:11
Number of Molecules:2
Biological Source:synthetic construct
Ligand Molecules
Primary Citation
Structure-Based Design of Non-natural Macrocyclic Peptides That Inhibit Protein-Protein Interactions.
J. Med. Chem. 60 8982 8988 (2017)
PMID: 29028171 DOI: 10.1021/acs.jmedchem.7b01221

Abstact

Macrocyclic peptides can interfere with challenging biomolecular targets including protein-protein interactions. Whereas there are various approaches that facilitate the identification of peptide-derived ligands, their evolution into higher affinity binders remains a major hurdle. We report a virtual screen based on molecular docking that allows the affinity maturation of macrocyclic peptides taking non-natural amino acids into consideration. These macrocycles bear large and flexible substituents that usually complicate the use of docking approaches. A virtual library containing more than 1400 structures was screened against the target focusing on docking poses with the core structure resembling a known bioactive conformation. Based on this screen, a macrocyclic peptide 22 involving two non-natural amino acids was evolved showing increased target affinity and biological activity. Predicted binding modes were verified by X-ray crystallography. The presented workflow allows the screening of large macrocyclic peptides with diverse modifications thereby expanding the accessible chemical space and reducing synthetic efforts.

Legend

Protein

Chemical

Disease

Primary Citation of related structures